Gsa Capital Partners LLP Vbi Vaccines Inc Transaction History

Gsa Capital Partners LLP

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 14, 2022	SELL	$0.73 - $23.4 $31,113 - $997,331	-42,621 Reduced 6.39%	624,438 $441,000
Q2 2022 Aug 09, 2022	BUY	$0.66 - $1.81 $364,118 - $998,566	551,694 Added 478.22%	667,059 $539,000
Q1 2022 May 11, 2022	BUY	$1.27 - $2.47 $6,799 - $13,224	5,354 Added 4.87%	115,365 $192,000
Q4 2021 Feb 14, 2022	BUY	$2.21 - $3.22 $243,124 - $354,235	110,011 New	110,011 $257,000
Q3 2021 Nov 12, 2021	SELL	$2.8 - $3.72 $525,728 - $698,467	-187,760 Closed	0 $0
Q2 2021 Aug 05, 2021	BUY	$2.61 - $4.17 $166,105 - $265,387	63,642 Added 51.28%	187,760 $629,000
Q1 2021 May 10, 2021	SELL	$2.91 - $4.32 $12,233 - $18,161	-4,204 Reduced 3.28%	124,118 $386,000
Q4 2020 Feb 03, 2021	BUY	$2.15 - $3.5 $104,156 - $169,557	48,445 Added 60.65%	128,322 $353,000
Q3 2020 Nov 06, 2020	BUY	$2.77 - $6.17 $221,259 - $492,841	79,877 New	79,877 $228,000

688K

Ticker VBIV
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 258,256,992
Market Cap $5.17M
Description
VBI Vaccines Inc., a biopharmaceutical company, develops and sells vaccines for the treatment of infectious diseases and immuno-oncology. The company offers Sci-B-Vac, a prophylactic hepatitis B (HBV) vaccine. It also engages in the development of VBI-2601 (BRII-179), an immunotherapeutic candidate for the treatment of chronic HBV infection. The...

Get notified when there are updates to the investment portfolio of Gsa Capital Partners LLP, based on Form 13F filings with the SEC.

Stay updated on Gsa Capital Partners LLP with notifications on news.